1. 17β-estradiol/progesterone in a single, oral, softgel capsule (TX-001HR) significantly increased the number of vasomotor symptom-free days in the REPLENISH trial. Issue 12 (December 2020) Authors: Kaunitz, Andrew M.; Bitner, Diana; Constantine, Ginger D.; Bernick, Brian; Graham, Shelli; Mirkin, Sebastian Journal: Menopause Issue: Volume 27:Issue 12(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗